Ashley Akinrimisi Biography: Meet Shaffy Bello’s Daughter

Ashley Akinrimisi is a Nigerian vlogger, model, and fashionista who is the daughter of popular actress and singer, Shaffy Bello.

If you haven’t read Ashley Akinrimisi Biography, there are facts you need to know about her.

Ashley Akinrimisi Biography

Ashley Akinrimisi was born on November 23, 1996, in the United States before she relocated to Nigeria with her mother.

Not much is known about her, although she is gradually coming into the entertainment industry.

Ashley Akinrimisi Parents

Ashley’s parents are Shaffy Bello and Mr. Akinrimisi who are happily married.

She also has a brother named Ashton, with whom they grow up together.

Conclusion

Shaffy Bello is a successful actress with a happy family of two children and her beloved husband.

Shaffy Bello’s daughter is doing well as a vlogger and model.

While the daughter is doing well, much information is not revealed about Shaffy Bello’s son.

Ashley Akinrimisi Pictures

Thanks for reading, please share on your favorite social media channels.

You May Also Like

Randal Kirk’s Net Worth, Biography, Career, Awards, Fact and Life Story

Randal Kirk net worth: Randal Kirk is an American businessman who has an estimated net worth of $3.6 billion dollars. Born in Pleasonton, California, Randal Kirk moved around a great deal as a child, since his father was in the military. He earned his undergraduate degree from Radford University in Economics, and then went on to earn a law degree from the University of Virginia. In the mid-80s, he co-founded General Injectables and Vaccines, a Virginia-based pharmaceuticals company. The company spun off another pharmaceuticals company, based in Tennessee, called King Pharmaceuticals. The co-founders subsequently split, with each one taking a company. Mr. Kirk sold his portion for $65 million in cash. He then founded New River Pharmaceuticals in the mid-90s, and became CEO in 2001. He sold the company for $2.6 billion in 2007. He then launched a management investment firm, and another pharmaceutical company, called Clinical Data. He sold Clinical Data for $2.1 billion in 2011. He is currently focused on his new company, Intrexon.
Read More